tradingkey.logo
搜尋

Bausch + Lomb Corp

BLCO
添加自選
16.540USD
-0.090-0.54%
收盤 06/30, 16:00美東報價延遲15分鐘
5.86B總市值
虧損本益比TTM

Bausch + Lomb Corp

16.540
-0.090-0.54%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.54%

5天

+10.78%

1月

+5.69%

6月

-3.56%

今年開始到現在

-3.16%

1年

+33.39%

關鍵數據
16.620今開
16.660最高
394.40K成交量
虧損本益比TTM
14.83本益比動
--股利TTM
0.11%換手率
16.630昨收
16.320最低
3.73M成交額
虧損本益比靜
0.91市淨率
0.00%股息率 TTM
-1.55%ROA
18.91552週最高
1.11量比
-317.00M淨利潤
354.21M總股本
-0.6165每股盈餘TTM
0.58Beta
-3.44%ROE
11.22052週最低
2.04%振幅
56.59%毛利率
5.86B總市值
4.18回報/風險
1.93%風險率

TradingKey Bausch + Lomb Corp股票評分

單位: USD 更新時間: 2026-06-29

操作建議

Bausch + Lomb Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名74/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為18.09。中期看,股價處於平穩狀態。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bausch + Lomb Corp評分

相關信息

行業排名
74 / 204
全市場排名
179 / 4570
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Bausch + Lomb Corp亮點

亮點風險
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
業績高增長
公司營業收入穩步增長,連續3年增長23.03%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入5.10B美元
估值低估
公司最新PE估值-26.97,處於3年歷史低位
機構減倉
最新機構持股40.30M股,環比減少38.29%
拉里·羅賓斯持倉
明星投資者拉里·羅賓斯持倉,最新持倉1.93M股

分析師目標

基於 12 分析師
持有
評級
18.091
目標均價
+10.85%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bausch + Lomb Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bausch + Lomb Corp簡介

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
公司代碼BLCO
公司Bausch + Lomb Corp
CEOSaunders (Brenton L)
網址https://ir.bausch.com/

常見問題

Bausch + Lomb Corp(BLCO)的當前股價是多少?

Bausch + Lomb Corp(BLCO)的當前股價是 16.64。

Bausch + Lomb Corp 的股票代碼是什麼?

Bausch + Lomb Corp的股票代碼是BLCO。

Bausch + Lomb Corp股票的52週最高點是多少?

Bausch + Lomb Corp股票的52週最高點是18.91。

Bausch + Lomb Corp股票的52週最低點是多少?

Bausch + Lomb Corp股票的52週最低點是11.22。

Bausch + Lomb Corp的市值是多少?

Bausch + Lomb Corp的市值是5.94B。

現在Bausch + Lomb Corp(BLCO)的股票是買入、持有還是賣出?

根據分析師評級,Bausch + Lomb Corp(BLCO)的總體評級為signal_hold,目標價格為18.09。

Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是多少

Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是-1.02。
KeyAI